A plain-language summary of the cited sources below. Informational only — not medical advice.
Clonidine lowers blood pressure and heart rate by reducing the body's stress response signals. It works primarily in the brain, where it mimics the action of a natural chemical called norepinephrine at specific receptor sites. This calms the nervous system's 'fight or flight' activity, which in turn reduces how hard the heart works and how tightly blood vessels constrict. Clonidine also binds to receptors in the brainstem that help control cardiovascular responses, and it can dampen pain signals travelling through the spinal cord. These combined effects mean the medication influences arousal, attention, and physical stress responses.
In Australia, clonidine is approved for treating acute high blood pressure emergencies and as an alternative when someone can't take medication by mouth. It stays in the body for quite a while—the half-life ranges from nine to twenty-six hours in people with healthy kidneys, and much longer if kidney function is impaired.
Your family member may experience dizziness or drowsiness, especially when standing up quickly, because the medication lowers blood pressure. Dry mouth is common, as are constipation, nausea, and sometimes vomiting or salivary gland discomfort. Some people notice low mood or changes in sleep patterns while taking clonidine.
Serious side effects are less common but need urgent medical attention. These include very slow heart rate, heart rhythm disturbances affecting the heart's electrical conduction, and a bowel condition called colonic pseudo-obstruction where the intestine stops moving normally. There have also been cases of liver inflammation reported.
Clonidine should not be used in people with known allergy to the active ingredient, or in those with certain severe heart rhythm problems—specifically very slow heart rhythms caused by sick sinus syndrome or second- or third-degree heart block. The medication contains excipients that may not be suitable for people with certain rare hereditary conditions. If your family member takes clonidine long-term, their heart rate and blood pressure will need regular monitoring, and the dose may need adjustment if their kidney function changes.
“The hypotensive effect of CLONIDINE HYDROCHLORIDE is produced mostly by its central effect or reducing sympathetic drive.”
“The terminal elimination half-life of clonidine has been found to range from 9-26 hours in patients with normal renal function.”
A plain-language summary of the cited sources below. Informational only — not medical advice.
Clonidine is a centrally acting α2-adrenoceptor agonist that reduces sympathetic outflow, producing hypotensive and sedative effects. It acts primarily at α2A, α2B, and α2C receptors in the CNS and periphery, with additional activity at imidazoline I1 receptors in brainstem cardiovascular centres. Through these mechanisms clonidine lowers arterial pressure, heart rate, and total peripheral resistance; it also decreases noradrenergic arousal signaling in the ascending reticular activating system and modulates prefrontal cortical network activity relevant to attention.
TGA-approved indications are acute hypertensive crisis and situations where oral therapy is inappropriate. The terminal elimination half-life ranges from 9–26 hours in patients with normal renal function, extending to 41 hours in kidney failure and 48 hours with repeated dosing. Common adverse effects include sedation, dizziness, orthostatic hypotension, dry mouth, constipation, and sleep disturbance. Contraindications include severe bradyarrhythmia from sick sinus syndrome or second- or third-degree AV block, and known hypersensitivity to clonidine. Serious adverse effects reported include atrioventricular block, sinus bradycardia, colonic pseudo-obstruction, and cases of hepatitis.
Working under the parallel aged-care framework? Aged-care equivalent →
Curated subset. The full adverse-effect list is in the TGA Product Information; click any citation above to open it.